General
This document explains the mission statement, core values, and health promotion team vision of the Southeast Region Health Promotion Team. Staff and contact information listing.
This document explains the mission statement, core values, and health promotion team vision of the Southeast Region Health Promotion Team. Staff and contact information listing.
Increased Numbers of West Nile Cases in New Mexico in 2023 - August 18, 2023
As the number of COVID-19 cases rises across the US, the New Mexico Department of Health recommends that providers prescribe Paxlovid (nirmatrelvir/ritonavir) to all appropriate patients diagnosed with COVID-19. Paxlovid, an oral antiviral, is a highly effective treatment for COVID-19 but continues to be under prescribed by providers1. Support for the use of Paxlovid comes from several randomized trials and observational studies of symptomatic outpatients with COVID-19, which demonstrated a reduction in hospitalization and death.
Typhoid and Paratyphoid Fevers (Salmonella Typhi, Paratyphi A and B)
Typhoid Fever Factsheet (English)
Typhoid Fever Factsheet (Spanish)
The Supports Waiver was approved by Centers for Medicare & Medicaid Services (CMS) effective July 1, 2020. The Supports Waiver is an option for individuals who are on the Home and Community Based Waivers, Developmental Disabilities (DD) Waiver Wait List.
Pseudomonas
Pseudomonas Factsheet (English)
Pseudomonas Factsheet (Spanish)
LLCP Mission Vision Values handout
Intake and Eligibility Regional Contacts
New and Improved Application Process for DD and Mi Via Waivers
Haemophilus Influenzae Invasive Disease
Haemophilus Factsheet (English)
Haemophilus Influenza Tipo B Factsheet (Spanish)
Norovirus Infections
CD Manual - Monkey Pox
Clarification of Expectations for the Collaborative-Consultative (C-C) Model (2021 DDW Standards section 12.4.2)
SW Numbered Memo 2023-02 DDSD Annual Report Links 2023